Sphingomyelin is a type of fat molecule found in the membranes of nearly every cell in your body, with especially high concentrations in nerve tissue and the brain. It belongs to a family of lipids called sphingolipids, and it plays a central role in protecting nerve fibers, organizing cell membranes, and relaying signals between cells. Its name comes from the sphinx, reflecting the mystery surrounding its function when scientists first discovered it in brain tissue in the 1880s.
What Sphingomyelin Is Made Of
Sphingomyelin is built from four basic components: a long-chain molecule called sphingosine, a fatty acid, a phosphate group, and choline. The sphingosine backbone is an 18-carbon chain with a double bond partway along its length, giving the molecule a slight kink. A fatty acid attaches to the sphingosine through a specific bond, forming a unit called ceramide. Then a phosphocholine group links to the ceramide’s free end.
This structure makes sphingomyelin a phospholipid, similar in some ways to the more common phospholipids built on a glycerol backbone. But the ceramide portion gives sphingomyelin distinct physical properties. It packs tightly with neighboring molecules, creating stiffer, more organized patches within cell membranes. This rigidity turns out to be essential for several of the molecule’s biological roles.
Its Role in Nerve Insulation
The most well-known job of sphingomyelin is helping form the myelin sheath, the fatty wrapping that insulates nerve fibers and allows electrical signals to travel quickly along them. Sphingomyelin is an essential structural and functional component of myelin membranes, and its levels closely track the development of this insulation. In animal studies, sphingomyelin content rises massively during the first 30 days after birth, matching the timing of myelin sheath maturation around nerve fibers.
When myelin breaks down, as it does in certain neurological diseases, sphingomyelin levels in the fluid surrounding the brain and spinal cord change in measurable ways. In people with peripheral demyelinating neuropathies (conditions where myelin in the body’s outer nerves degrades), sphingomyelin levels correlate inversely with nerve conduction speed. That means as sphingomyelin rises in spinal fluid, indicating myelin breakdown, signals travel more slowly through affected nerves. Sphingomyelin measurements can even distinguish between nerve damage caused by myelin loss and nerve damage caused by injury to the nerve fiber itself.
Organizing the Cell Membrane
Beyond nerve insulation, sphingomyelin serves a structural role in cell membranes throughout the body. It partners with cholesterol to form small, organized patches within the membrane called lipid rafts. These rafts exist in a more ordered, tightly packed state compared to the looser, more fluid regions of the membrane surrounding them. The concept was formalized in 1997 and has since become central to understanding how cells organize their surfaces.
Lipid rafts aren’t just structural curiosities. They act as platforms where signaling proteins gather, concentrate, and interact. Specific proteins are drawn to these cholesterol-sphingomyelin patches, and their clustering there helps coordinate processes like cell growth, survival, and the transport of materials in and out of the cell. Sphingomyelin also helps regulate the flow of tiny membrane-bound packages (vesicles) that carry molecules between different compartments inside cells.
Ceramide and Cell Signaling
One of the most biologically active things that happens to sphingomyelin is its breakdown. Enzymes called sphingomyelinases cut sphingomyelin into two pieces: ceramide and phosphocholine. Ceramide is a potent signaling molecule that influences whether cells grow, stop growing, or die.
Three main types of sphingomyelinase exist in the body, each working at a different pH and in a different location. Acid sphingomyelinase operates inside lysosomes (the cell’s recycling centers) and at the cell surface, with particularly high levels in the cells lining blood vessels, where its expression can be up to 20 times higher than in liver or kidney cells. Neutral sphingomyelinase works at the cell membrane and in the surrounding fluid. Alkaline sphingomyelinase functions in the intestine, where it digests sphingomyelin from food.
When ceramide accumulates in lipid rafts, it can recruit specific proteins that shut down pro-growth and pro-survival pathways. For instance, ceramide-enriched membrane regions can inactivate a key survival signal called Akt through multiple mechanisms, effectively telling a cell to stop dividing or to begin self-destruction. This makes the sphingomyelin-to-ceramide conversion a critical checkpoint in how cells respond to stress, infection, and damage.
Sphingomyelin in Food
Sphingomyelin is one of the most common sphingolipids in animal tissues, and you consume it regularly through dairy products, eggs, and meat. It’s also added to infant formula because of its importance in early brain development and myelin formation.
When you eat sphingomyelin, alkaline sphingomyelinase in your small intestine breaks it down into ceramide and phosphocholine. A second enzyme, neutral ceramidase, then breaks the ceramide further into sphingosine and free fatty acids. These smaller building blocks are absorbed through the intestinal wall and can be reassembled into new sphingolipids as the body needs them.
Niemann-Pick Disease: When Breakdown Fails
The clearest example of what goes wrong without proper sphingomyelin metabolism is Niemann-Pick disease types A and B. Both are caused by a deficiency in acid sphingomyelinase, the enzyme responsible for breaking down sphingomyelin inside lysosomes. Without enough of this enzyme, sphingomyelin accumulates in cells throughout the body, damaging organs progressively.
Type A is the more severe form. It typically appears in the first three months of life with an enlarged liver and spleen and poor growth. By age one, neurological symptoms emerge: children lose developmental milestones they had already reached. A characteristic finding on eye examination is a cherry-red spot on the retina. Children with type A rarely survive past early childhood.
Type B appears later, usually in mid-childhood, and progresses more slowly. The liver and spleen enlarge, and interstitial lung disease causes recurring respiratory infections. Bone growth slows, and blood platelet counts drop. About one-third of type B patients also develop the cherry-red eye spot and neurological symptoms. Diagnosis for both types involves measuring acid sphingomyelinase activity in a blood sample, followed by genetic testing if enzyme levels are low.
Connections to Neurological Disease
Sphingomyelin levels in spinal fluid have drawn interest as a potential marker for diseases involving myelin damage. In multiple sclerosis, sphingomyelin levels in cerebrospinal fluid tend to be lower compared to other neurological diseases. By contrast, in neuromyelitis optica spectrum disorder, a condition sometimes confused with MS, sphingomyelin levels are significantly higher than in MS. This difference likely reflects distinct patterns of myelin destruction: when myelin breaks down more aggressively, more sphingomyelin is released into the surrounding fluid.
These differences are already proving useful in a clinical context. Sphingolipid profiles in spinal fluid can help distinguish between neuromyelitis optica spectrum disorder and multiple sclerosis, two conditions that look similar on the surface but require different treatment approaches. The ability to measure myelin-enriched lipids like sphingomyelin adds a biochemical dimension to diagnosis that complements imaging and neurological exams.